journal article·2019-12-04Open access

Facile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aim

Hamed Nosrati, Fatemeh Abhari, Jalil Charmi, Mohammad Rahmati, Behrooz Johari, Sedigheh Azizi, Hamed Rezaeejam, Hossein Danafar

Abstract

High atomic number Z, nanoparticles are able to enhance the photoelectric and Compton effects under X-Ray irradiation resulting the increase of radiation therapy efficacy. To achieve enhanced radiation therapy, Bi2S3 biocompatible particles coated with bovine serum albumin (BSA) (Bi2S3@BSA HNPs) were prepared through a BSA-mediated biomineralization procedure under green conditions. Then, to achieve improved chemo-radiation therapy against HT-29 cancer cells, curcumin (CUR) as natural anti-cancer therapy agent loaded on the Bi2S3@BSA (Bi2S3@BSA@CUR HNPs). Next, this synthesized nanodrug was evaluated for physical and chemical properties and in vitro cytotoxicity studies. Here, in vitro enhanced chemo-radiation combination therapy power was evaluated against HT-29 cell line under 2 Gy and 6 Gy X-ray irradiation doses. The Bi2S3@BSA HNPs without irradiation rarely affect cell viability which shown the non-toxicity of Bi2S3@BSA HNPs. The result of this study proved that Bi2S3@BSA@CUR HNPs can be used as both proficient vehicles for effective delivery of CUR and radiosensitizer in the treatment of cancer. In addition, the result of this study confirmed that the combination of high Z-element nanoradiosensitizer, Bi2S3@BSA HNPs, with a natural anti-cancer drug, CUR, enhanced therapeutic power against HT-29 cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Biomaterials, School of Pharmacy, Zanjan University of Medical Sciences

Department of Medical Physics, Faculty of Medicine, Tabriz University of Medical Sciences

Department of Physics, Faculty of Science, University of Zanjan

Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences

Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences

Department of Radiology, School of Paramedical and Health, Zanjan University of Medical Sciences

References (32)

Show source-provided references
1. 10.1016/j.tips.2017.11.00310.1016/j.tips.2017.11.003 ↗
2. 10.1021/acsbiomaterials.9b0048910.1021/acsbiomaterials.9b00489 ↗
3. 10.1021/ja412001e10.1021/ja412001e ↗
4. 10.1002/ange.20110494310.1002/ange.201104943 ↗
5. 10.1021/acsnano.8b0203810.1021/acsnano.8b02038 ↗
6. 10.1016/j.materresbull.2013.05.09110.1016/j.materresbull.2013.05.091 ↗
7. 10.1021/acsami.7b1783810.1021/acsami.7b17838 ↗
8. 10.1021/acsami.7b1849310.1021/acsami.7b18493 ↗
9. 10.1002/anie.20110772410.1002/anie.201107724 ↗
10. 10.1016/j.biocel.2008.06.01010.1016/j.biocel.2008.06.010 ↗
11. 10.1039/c1np00051a10.1039/c1np00051a ↗
12. Pochampally R, John V, Alb A, et al. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed Cancer Pan Stanford. 2017;8:291–322.
13. 10.1039/C5NR07918G10.1039/C5NR07918G ↗
14. 10.1002/adfm.20160134110.1002/adfm.201601341 ↗
15. 10.1021/acs.chemrev.5b0011610.1021/acs.chemrev.5b00116 ↗
16. 10.1126/science.122633810.1126/science.1226338 ↗
17. 10.1039/c3cc41141a10.1039/c3cc41141a ↗
18. 10.1021/ja806804u10.1021/ja806804u ↗
19. 10.1021/la904389y10.1021/la904389y ↗
20. 10.1021/jp710597j10.1021/jp710597j ↗
21. 10.1021/jp710830310.1021/jp7108303 ↗
22. 10.1021/acs.bioconjchem.9b0000610.1021/acs.bioconjchem.9b00006 ↗
23. 10.1039/C4RA07300B10.1039/C4RA07300B ↗
24. 10.1166/jnn.2008.1838010.1166/jnn.2008.18380 ↗
25. 10.1021/cm052205i10.1021/cm052205i ↗
26. 10.1016/j.ijpharm.2009.05.00410.1016/j.ijpharm.2009.05.004 ↗
27. 10.1002/anie.20070503410.1002/anie.200705034 ↗
28. 10.1002/anie.20089009010.1002/anie.200890090 ↗
29. 10.1021/acs.iecr.6b0453210.1021/acs.iecr.6b04532 ↗
30. 10.1016/j.biomaterials.2018.01.04710.1016/j.biomaterials.2018.01.047 ↗
31. 10.1002/adma.20150300610.1002/adma.201503006 ↗
32. 10.1016/j.biomaterials.2011.08.08610.1016/j.biomaterials.2011.08.086 ↗